ANA, anti-dsDNA, anti-Ro, anti-La, anti-RNP, anti-Sm, antiphospholipid antibodies, C3 and C4 at baseline

at baseline: ANA, anti-dsDNA, anti-Ro, anti-La, anti-RNP, anti-Sm, anti-phospholipid, C3, C4

tests per year, Europe, at baseline

“We recommend the monitoring of the following autoantibodies and complement: at baseline: ANA, anti-dsDNA, anti-Ro, anti-La, anti-RNP, anti-Sm, anti-phospholipid, C3, C4”

EULAR recommendations for monitoring patients with SLE in clinical practice and in observational studies (Mosca et al., Ann Rheum Dis 2010), Table of recommendations, 2010-07

Kind of source
Clinical guideline
Read on
2026-11-06
Daily check
Quote found at the source on 2026-11-06
What to know
A one-off baseline panel at diagnosis or entry to care. Anti-dsDNA and C3/C4 are then repeated to follow disease activity, and antiphospholipid and anti-Ro/La antibodies are re-checked before pregnancy or surgery.

Used in

Kept as evidence; no figure on the platform is computed from it yet.